• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

志愿者皮下给予芬太尼后的药代动力学。

Pharmacokinetics of fentanyl after subcutaneous administration in volunteers.

机构信息

Department of Anaesthesia and Intensive Care, Royal Adelaide Hospital, University of Adelaide, Adelaide, Australia.

出版信息

Eur J Anaesthesiol. 2010 Mar;27(3):241-6. doi: 10.1097/EJA.0b013e328331a361.

DOI:10.1097/EJA.0b013e328331a361
PMID:19918182
Abstract

BACKGROUND AND OBJECTIVE

Pain relief using intermittent subcutaneous injections of an opioid (e.g. morphine) avoids the need for venous access and does not require complex or expensive pumps and devices. Although data on the pharmacokinetics of subcutaneous morphine exist, there are no comparable data for fentanyl in healthy volunteers. Therefore, the aim of this study was to characterize the pharmacokinetics of 200 microg fentanyl administered as a single bolus dose via the subcutaneous route in healthy opioid-naive volunteers.

METHODS

Nine healthy male volunteers were given 200 microg of subcutaneous fentanyl for more than 30 s. Opioid effects were blocked by administration of naltrexone. Venous blood samples taken at intervals from 5 min to 10 h after the dose were assayed using a liquid chromatography-mass spectrometry method. Pharmacokinetic data were analysed using a noncompartmental analysis approach.

RESULTS

After subcutaneous bolus dose administration, the median maximum concentration of fentanyl was 0.55 ng ml(-1) (range 0.28-0.87 ng ml(-1)), reached at a median time of 15 min (range 10-30 min). The terminal half-life was 10.00 h (range 5.48-16.37 h).

CONCLUSION

Absorption of subcutaneous fentanyl was relatively rapid and similar to the rate of absorption previously reported for subcutaneous morphine; the terminal half-life for fentanyl was substantially longer (10 h) than that of morphine (2.1 h), and blood concentrations were no more variable than that after administration by other nonintravenous routes.

摘要

背景与目的

使用阿片类药物(如吗啡)间歇性皮下注射来缓解疼痛,可避免静脉通路的需要,且不需要复杂或昂贵的泵和设备。虽然有关于皮下注射吗啡药代动力学的数据,但在健康志愿者中,没有类似芬太尼的数据。因此,本研究的目的是描述健康的阿片类药物初治志愿者单次皮下给予 200μg 芬太尼时的药代动力学特征。

方法

9 名健康男性志愿者接受超过 30 秒的 200μg 芬太尼皮下注射。给予纳曲酮阻断阿片类药物的作用。在给药后 5 分钟至 10 小时的间隔时间内采集静脉血样,使用液相色谱-质谱法进行检测。使用非房室分析方法对药代动力学数据进行分析。

结果

皮下推注给药后,芬太尼的中位数最大浓度为 0.55ng/ml(范围 0.28-0.87ng/ml),中位数达峰时间为 15 分钟(范围 10-30 分钟)。终末半衰期为 10.00 小时(范围 5.48-16.37 小时)。

结论

皮下芬太尼的吸收相对较快,与先前报告的皮下吗啡吸收速率相似;芬太尼的终末半衰期明显长(10 小时)于吗啡(2.1 小时),且血药浓度的变异性不比其他非静脉途径给药后更大。

相似文献

1
Pharmacokinetics of fentanyl after subcutaneous administration in volunteers.志愿者皮下给予芬太尼后的药代动力学。
Eur J Anaesthesiol. 2010 Mar;27(3):241-6. doi: 10.1097/EJA.0b013e328331a361.
2
Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.芬太尼泡腾颊片(FEBT)1080微克与口腔黏膜枸橼酸芬太尼1600微克的相对生物利用度以及FEBT 270至1300微克的剂量比例:一项在健康成年志愿者中进行的单剂量、随机、开放标签、三周期研究。
Clin Ther. 2006 May;28(5):715-24. doi: 10.1016/j.clinthera.2006.05.016.
3
Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 microg in healthy adult volunteers.芬太尼泡腾颊含片的药代动力学特性:一项在健康成年志愿者中进行的单剂量100、200、400和800微克的I期开放标签交叉研究。
Clin Ther. 2006 May;28(5):707-14. doi: 10.1016/j.clinthera.2006.05.015.
4
Single-dose and steady-state pharmacokinetics of fentanyl buccal tablet in healthy volunteers.芬太尼口腔崩解片在健康志愿者中的单剂量及稳态药代动力学
J Clin Pharmacol. 2007 Jan;47(1):56-63. doi: 10.1177/0091270006294129.
5
Evaluation of the single- and multiple-dose pharmacokinetics of fentanyl buccal soluble film in normal healthy volunteers.评价芬太尼口腔黏膜溶解片在健康志愿者中单剂量和多剂量的药代动力学。
J Clin Pharmacol. 2010 Jul;50(7):785-91. doi: 10.1177/0091270010361354. Epub 2010 Feb 11.
6
Pharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgery.口腔手术后疼痛患者中鼻内给予与静脉给予芬太尼的药代动力学和药效学
Ann Pharmacother. 2008 Oct;42(10):1380-7. doi: 10.1345/aph.1L168. Epub 2008 Aug 26.
7
Pharmacokinetics of fentanyl after intravenous and transdermal administration in goats.山羊静脉注射和经皮给药后芬太尼的药代动力学
Am J Vet Res. 1999 Aug;60(8):986-91.
8
Pharmacokinetics, efficacy, and tolerability of fentanyl following intranasal versus intravenous administration in adults undergoing third-molar extraction: a randomized, double-blind, double-dummy, two-way, crossover study.成人拔除第三磨牙时经鼻与静脉注射芬太尼后的药代动力学、疗效及耐受性:一项随机、双盲、双模拟、双向交叉研究。
Clin Ther. 2008 Mar;30(3):469-81. doi: 10.1016/j.clinthera.2008.03.001.
9
Pharmacokinetics and dose selection of a novel, long-acting transdermal fentanyl solution in healthy laboratory Beagles.新型长效透皮芬太尼溶液在健康实验比格犬体内的药代动力学及剂量选择
J Vet Pharmacol Ther. 2012 Aug;35 Suppl 2:21-6. doi: 10.1111/j.1365-2885.2012.01399.x.
10
Disposition of transdermally administered fentanyl in dogs.经皮给药的芬太尼在犬体内的处置情况。
Am J Vet Res. 1996 May;57(5):715-9.

引用本文的文献

1
Dual-Atom Catalyst Au@S-rGO for Rapid and Highly Sensitive Electrochemical Detection of Fentanyl in Serum.用于血清中芬太尼快速高灵敏电化学检测的双原子催化剂Au@S-rGO
Adv Sci (Weinh). 2025 May;12(18):e2500430. doi: 10.1002/advs.202500430. Epub 2025 Mar 16.
2
Comparing the Efficacy of Fentanyl Nasal Packing on Postoperative Pain in Patients Undergoing Nasal Surgeries Versus Normal Saline Pack-A Randomized Control Trial.比较芬太尼鼻腔填塞与生理盐水填塞对鼻腔手术患者术后疼痛的疗效——一项随机对照试验
Indian J Otolaryngol Head Neck Surg. 2025 Jan;77(1):265-270. doi: 10.1007/s12070-024-05166-w. Epub 2024 Nov 4.
3
A randomized controlled trial comparing the effect of intravenous, subcutaneous, and intranasal fentanyl for pain management in patients undergoing cesarean section.
一项比较静脉注射、皮下注射和鼻内注射芬太尼对剖宫产患者疼痛管理效果的随机对照试验。
Adv Biomed Res. 2016 Dec 27;5:198. doi: 10.4103/2277-9175.190989. eCollection 2016.
4
Treatment with subcutaneous and transdermal fentanyl: results from a population pharmacokinetic study in cancer patients.皮下和透皮芬太尼治疗:癌症患者群体药代动力学研究结果。
Eur J Clin Pharmacol. 2016 Apr;72(4):459-67. doi: 10.1007/s00228-015-2005-x. Epub 2016 Jan 14.
5
Pharmacokinetics of tramadol after subcutaneous administration in a critically ill population and in a healthy cohort.曲马多在危重症人群和健康队列中皮下给药后的药代动力学。
BMC Anesthesiol. 2014 May 12;14:33. doi: 10.1186/1471-2253-14-33. eCollection 2014.
6
Effects of prophylactic subcutaneous fentanyl on exercise-induced breakthrough dyspnea in cancer patients: a preliminary double-blind, randomized, controlled trial.预防性皮下注射芬太尼对癌症患者运动诱发的突破性呼吸困难的影响:一项初步的双盲、随机、对照试验。
J Pain Symptom Manage. 2014 Feb;47(2):209-17. doi: 10.1016/j.jpainsymman.2013.03.017. Epub 2013 Jul 3.